Andrea Maliachi
@andreamaliachi
🇲🇽🦀 Medical Oncologist | #BreastCancer | incansable
ID: 870165878091816960
01-06-2017 06:31:27
948 Tweet
597 Followers
524 Following
📣Just published! Our Systematic Review and Meta-Analysis about Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast Cancer, in JAMA Oncology JAMA Oncology Led by Guillermo Villacampa Tomás Pascual jamanetwork.com/journals/jamao…
Bispecific antibodies: advancing precision oncology Trends in Cancer doi.org/10.1016/j.trec… 👉Bispecific antibodies are on the rise with promising data 👏Excellent in depth review ESMO - Eur. Oncology
💉Vacunación en pacientes con #Cancer 💡Fundamental saber cuál, cuando y como aplicarlas Preceptoría de #Vacunas de la Asociación Argentina de Oncología Clínica (AAOC) + Sociedad Argentina Infectología
Excited to share our latest chapter on AI in Oncology as part of the work on the digitalization of medicine in low- and middle-income countries, alongside Prof Karine Sargsyan, Prof Zisis Kozlakidis and Prof Muradyan Check it ⬇️ link.springer.com/book/10.1007/9… Immune Oncology Research Institute Shushan Hovsepyan
🗓 Del próximo 23 al 25 de septiembre, te esperamos en la #FacMed con talleres, conferencias magistrales de Inteligencia Artificial en la salud o Telemedicina, hackatones GRATIS y más ✨ En colaboración con Ingeniería UNAM 🚀🌐 👉 Consulta todo el programa: congresosaluddigital.unam.mx
Nancy Lin, MD presents remarkable data from DB12 in patients with brain Mets. But breast docs need to understand PJP prophylaxis in patients on steroids! Published today in nature med. #ESMO2024
🎉 Excited to share our latest review in Nature Reviews Clinical Oncology! 🎉 NatureRevClinOncol 📖 We dive into the latest on dual #HER2 inhibition in #BreastCancer—exploring synergy, patient selection, and resistance. 🔬💥 Big steps forward in personalized treatment for
#ESMO24 HR+/HER2- Breast Cancer Treatment Guideline (ESMO - Eur. Oncology Pocket Guideline)